Topic: Alzheimer.
Destination: Grants to finance Phase I and Phase II clinical trials that evaluate medicines aimed at Alzheimer’s disease and other related dementias on an international scale.
Budget: $1.000.000.
Duration: 2 – 3 years.
Llena el siguiente formulario para recibir más información:
